UnitedHealth Group Incorporated (UNH) Shares Sold by Oak Associates Ltd. OH
Oak Associates Ltd. OH cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,300 shares of the healthcare conglomerate’s stock after selling 600 shares during the period. Oak Associates Ltd. OH’s holdings in UnitedHealth Group were worth $3,022,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. BlackRock Inc. grew its position in UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock valued at $12,873,786,000 after purchasing an additional 796,654 shares in the last quarter. Vanguard Group Inc. grew its position in UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. FMR LLC grew its position in UnitedHealth Group by 2.1% in the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after acquiring an additional 1,168,324 shares in the last quarter. Alliancebernstein L.P. grew its position in UnitedHealth Group by 2.3% in the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after acquiring an additional 174,290 shares in the last quarter. Finally, TIAA CREF Investment Management LLC grew its position in UnitedHealth Group by 3.9% in the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after acquiring an additional 223,524 shares in the last quarter. 86.20% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have commented on UNH. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, December 7th. Raymond James Financial reissued a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 6th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Finally, Oppenheimer boosted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $224.56.
In other news, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders sold 62,606 shares of company stock valued at $12,677,525 over the last 90 days. 0.89% of the stock is owned by corporate insiders.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up $1.86 during trading on Thursday, hitting $224.35. 3,059,400 shares of the stock were exchanged, compared to its average volume of 3,100,568. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group Incorporated has a twelve month low of $156.09 and a twelve month high of $231.77. The firm has a market capitalization of $216,240.00, a PE ratio of 23.17, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the previous year, the company earned $2.17 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.7% on a year-over-year basis. equities research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s payout ratio is 34.09%.
ILLEGAL ACTIVITY WARNING: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-shares-sold-by-oak-associates-ltd-oh/1763885.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.